Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients
Work
Year: 2019
Type: article
Abstract: Systemic lupus erythematosus (SLE) is a highly variable autoimmune disease that can involve severe organ-threatening symptoms, such as lupus nephritis. Certain drugs, such as mycophenolate mofetil (MM... more
Source: JCI Insight
Institutions Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Institute of Infection and Immunity, Stanford University
Cites: 55
Cited by: 44
Related to: 10
FWCI: 6.299
Citation percentile (by year/subfield): 99.99
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $4,100
Funders National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant IDS U54GM104938,P30GM103510,S10RR026735, U19AI082714,U19AI082719,U01AI101934,T32AI007633, RC1AR058554,P30AR053483